Inflammation and Fibrosis Markers Predict Adverse Outcomes in Arrhythmogenic Cardiomyopathy: An Integrated Multiomics Study
30 March 2025 (09:12 - 09:21)
Organised by: 

About the speaker

University Heart Center, Zurich (Switzerland)
5 More presentations in this session

Doctor N. Ullrich (Bern, CH)
Access the full session
The Event
EHRA 2025
30 March 2025
09:12 CET
You may be interested in
Congress Presentation
Congress Session







